Technology News and Research

RSS

Sophisticated IT leads to more robust and integrated communication strategies in clinical staff

The federal government invested more than $25 billion in health information technology (IT) as a result of the American Reinvestment and Recovery Act; yet, little is known about how IT applications improve patient safety and protect their privacy. Now, a University of Missouri nursing informatics expert suggests that sophisticated IT leads to more robust and integrated communication strategies among clinical staff, which allows staff to more efficiently coordinate care and better protect patient privacy.

11 Feb 2013

Shanshi, Tensys Medical enter commercial agreement to distribute T-Line technology

Tensys Medical, Inc., a leader in the development and commercialization of continuous, non-invasive hemodynamic patient monitoring systems, has entered into a commercial agreement with Zhejiang Shanshi Medical Device CO., LTD (Shanshi) for distribution of the company's T-Line technology.

11 Feb 2013

RNL BIO files new stem cell drug IND with KFDA to initiate phase II and III cerebral palsy trials

RNL BIO CO LTD (RNL) announced today the filing of an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to initiate clinical trials phase II and III assessing the company's RNL-Astrostem stem cell drug in patients with cerebral palsy.

11 Feb 2013

Harvard's Wyss Institute completes first clinical study of new rapid neuroassessment device

Doctors routinely track their patients' hand-eye coordination to monitor any neuromuscular deficits, particularly as patients age or when they are injured -- but the tests they have been using to track this kind of information may be subjective and qualitative.

10 Feb 2013

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

Biogen Idec and Swedish Orphan Biovitrum (Sobi) released data that confirmed the ability of investigational recombinant factors VIII Fc fusion protein (rFVIIIFc) and IX Fc fusion protein (rFIXFc) to provide long-lasting protection from bleeding with fewer injections than are required with the current standard of care for people with hemophilia.

10 Feb 2013

AHRQ, CMS announce new children's EHR format

The benefits of electronic health records (EHRs) may become more widely available to children through an EHR format for children's health care announced today by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) and Centers for Medicare & Medicaid Services (CMS).

10 Feb 2013

KFH/HP 2012 combined total operating revenue increases to $50.6 billion

Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their subsidiaries (KFH/HP) reported today that combined total operating revenue for 2012 was $50.6 billion, compared to $47.9 billion in 2011.

10 Feb 2013

Many pregnant women with sexually transmitted infections do not get needed treatment

Many pregnant women with sexually transmitted infections aren't getting the treatment they need when they visit emergency rooms, according to a new Michigan State University study that highlights a wholly preventable risk to unborn children and raises questions about current medical guidelines.

10 Feb 2013

Highlights for Feb. 2013 issue of Genetics journal

Listed below are the selected highlights for the February 2013 issue of the Genetics Society of America's journal, Genetics.

10 Feb 2013

Measuring cost-effectiveness of new medical technologies

To decide whether a new medical technology is cost effective, researchers often "compare a new technology's incremental cost-effectiveness ratio or ICER to a threshold that is some multiple of a country or income group's GDP per capita, per WHO convention," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the CGD's "Global Health Policy" blog

9 Feb 2013

Rekom Biotech designs new biomarkers that can identify West Nile virus, dengue

Researchers at the University of Granada have designed a set of biomarkers that can be used in diagnostic tests for the detection of dengue and the West Nile virus, two infectious diseases transmitted by the bite of a mosquito. These biomarkers can be used to identify these viral diseases, which affect millions of people worldwide.

9 Feb 2013

Investigators discover two new genes associated with severe early-onset disorders of heart rhythm

A team led by Vanderbilt University investigators has discovered two new genes - both coding for the signaling protein calmodulin - associated with severe early-onset disorders of heart rhythm.

7 Feb 2013

Society of Toxicology's 52nd Annual Meeting to be held from Mar. 10-16 in San Antonio

A group of 7,000 scientists working in multiple specialties, from more than 50 countries, will meet March 10-14, 2013 at the Henry B. Gonzalez Convention Center in San Antonio, Texas, to share their latest findings on 60 topical issues of concern to human health and the environment.

7 Feb 2013

Four-step process delivers specific, reliable clinical rules

Dutch researchers have developed a four-step strategy for formulating clinical decision support systems, which they say could help reduce “alert fatigue.”

7 Feb 2013

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Sangamo BioSciences, Inc. today reported fourth quarter and full year 2012 financial results and accomplishments.

7 Feb 2013

Seattle Genetics commences two SGN-CD19A phase I trials in hematologic malignancies

Seattle Genetics, Inc. today announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas.

6 Feb 2013

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

Deadly flu viruses, including the H5N1 bird flu and H3N2 swine flu, may have met their match in FluGen's universal vaccine, REDEE FLU.

6 Feb 2013

FDA approves Cardiva Medical's VASCADE Vascular Closure System

Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).

6 Feb 2013

Arzeda, INVISTA partner to develop new technologies to enable novel bio-derived processes

INVISTA Technologies S.à r.l. and Arzeda Corp. announce a collaboration for the development of new technologies to enable novel bio-derived processes.

6 Feb 2013

ECRI Institute PSO identifies key health information technology-related problems

The federal government is spending about $19 billion to encourage hospitals, physician practices, and other healthcare organizations to invest in their health information technology (HIT) infrastructure with the goal of improving patient safety and quality through the Health Information Technology for Economic and Clinical Health (HITECH) Act.

6 Feb 2013

Technology News and Research

Sophisticated IT leads to more robust and integrated communication strategies in clinical staff

Shanshi, Tensys Medical enter commercial agreement to distribute T-Line technology

RNL BIO files new stem cell drug IND with KFDA to initiate phase II and III cerebral palsy trials

Harvard's Wyss Institute completes first clinical study of new rapid neuroassessment device

Biogen Idec, Sobi release data from rFVIIIFc and rFIXFc phase 3 trials on hemophilia

AHRQ, CMS announce new children's EHR format

KFH/HP 2012 combined total operating revenue increases to $50.6 billion

Many pregnant women with sexually transmitted infections do not get needed treatment

Highlights for Feb. 2013 issue of Genetics journal

Measuring cost-effectiveness of new medical technologies

Rekom Biotech designs new biomarkers that can identify West Nile virus, dengue

Investigators discover two new genes associated with severe early-onset disorders of heart rhythm

Society of Toxicology's 52nd Annual Meeting to be held from Mar. 10-16 in San Antonio

Four-step process delivers specific, reliable clinical rules

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Seattle Genetics commences two SGN-CD19A phase I trials in hematologic malignancies

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

FDA approves Cardiva Medical's VASCADE Vascular Closure System

Arzeda, INVISTA partner to develop new technologies to enable novel bio-derived processes

ECRI Institute PSO identifies key health information technology-related problems

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News